We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.3B
AUM Growth
+$344M
Cap. Flow
-$120M
Cap. Flow %
-1.64%
Top 10 Hldgs %
25.93%
Holding
453
New
22
Increased
155
Reduced
213
Closed
25

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$71.7M
2
TFC icon
Truist Financial
TFC
+$56.3M
3
OXY icon
Occidental Petroleum
OXY
+$45.9M
4
VTR icon
Ventas
VTR
+$23.4M
5
SE
Spectra Energy Corp Wi
SE
+$23.1M

Top Sells

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$80.4M
2
KMI icon
Kinder Morgan
KMI
+$55.8M
3
MRSH
Marsh
MRSH
+$55.4M
4
USB icon
US Bancorp
USB
+$47.7M
5
TWX
Time Warner Inc
TWX
+$35.9M

Sector Composition

Rank Sector Weight
1 Technology 15.34%
2 Consumer Staples 15.34%
3 Financials 15.05%
4 Healthcare 14.65%
5 Industrials 12.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALOG
301
DELISTED
Analogic Corp
ALOG
$555K 0.01%
6,721
+510
+8% +$43.4K
GK
302
DELISTED
G&K Services Inc
GK
$550K 0.01%
8,745
+780
+10% +$51.9K
MS icon
303
Morgan Stanley
MS
$336B
$534K 0.01%
16,785
-2,624
-14% -$87.2K
TM icon
304
Toyota
TM
$222B
$525K 0.01%
4,270
-20
-0.5% -$2.47K
BNY
305
Bank of New York Mellon
BNY
$108B
$524K 0.01%
12,712
-122
-1% -$5.13K
SIMO icon
306
Silicon Motion
SIMO
$9.07B
$524K 0.01%
+16,725
New +$524K
TMO icon
307
Thermo Fisher Scientific
TMO
$214B
$510K 0.01%
3,595
-200
-5% -$26.7K
SEMG
308
DELISTED
SEMGROUP CORPORATION
SEMG
$510K 0.01%
17,670
+9,630
+120% +$369K
LEG icon
309
Leggett & Platt
LEG
$1.31B
$509K 0.01%
12,110
+300
+3% +$13.3K
MATV icon
310
Mativ Holdings
MATV
$644M
$506K 0.01%
12,045
+125
+1% +$5K
HPE icon
311
Hewlett Packard
HPE
$69.4B
$504K 0.01%
+57,052
New +$478K
SON icon
312
Sonoco
SON
$5.64B
$501K 0.01%
12,250
+290
+2% +$12.1K
SBUX icon
313
Starbucks
SBUX
$120B
$493K 0.01%
8,220
+2,560
+45% +$156K
WWW icon
314
Wolverine World Wide
WWW
$1.56B
$492K 0.01%
29,396
+2,170
+8% +$40.7K
NEOG icon
315
Neogen
NEOG
$2.46B
$485K 0.01%
22,872
+1,888
+9% +$38.5K
ISIL
316
DELISTED
Intersil Corp
ISIL
$458K 0.01%
35,920
+3,220
+10% +$42.7K
DD icon
317
DuPont de Nemours
DD
$19.5B
$456K 0.01%
3,499
-4,460
-56% -$573K
TECH icon
318
Bio-Techne
TECH
$11.2B
$455K 0.01%
20,220
+1,860
+10% +$42.4K
EPD icon
319
Enterprise Products Partners
EPD
$82.3B
$454K 0.01%
17,736
-500
-3% -$13K
IVV icon
320
iShares Core S&P 500 ETF
IVV
$897B
$450K 0.01%
2,196
+240
+12% +$49.6K
NBL
321
DELISTED
Noble Energy, Inc.
NBL
$450K 0.01%
13,670
BNS icon
322
Scotiabank
BNS
$108B
$446K 0.01%
11,263
-2,998
-21% -$129K
SYT
323
DELISTED
Syngenta Ag
SYT
$436K 0.01%
5,540
-30
-0.5% -$2.15K
AMJ
324
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$435K 0.01%
15,000
CRI icon
325
Carter's
CRI
$1.48B
$431K 0.01%
4,845
-16
-0.3% -$1.43K

Similar funds

Bahl & Gaynor's Q4 2015 Portfolio in Review

As of Q4 2015, Bahl & Gaynor held 453 positions worth $7.3B, up 4.9% from $6.96B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Bahl & Gaynor's Q4 2015 filing shows 22 new, 155 increased, 213 reduced and 25 closed positions. Its largest new stake was Equifax: 109,123 shares worth $12.2M. The largest sale was Williams Companies, an estimated $80.4M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Staples and Financials.

  • Bahl & Gaynor's largest Q4 2015 buy was Equifax: 109,123 shares worth $12.2M.
  • Bahl & Gaynor added most to Crown Castle in Q4 2015, an estimated $71.7M increase.
  • Bahl & Gaynor's biggest Q4 2015 reduction was Williams Companies, cutting an estimated $80.4M.
  • Bahl & Gaynor fully exited Kinder Morgan in Q4 2015, selling an estimated $55.8M.
  • Bahl & Gaynor's ten largest holdings make up 26% of its $7.3B portfolio in Q4 2015.
  • Bahl & Gaynor opened 22 new positions and closed 25 in Q4 2015.
  • Bahl & Gaynor's portfolio value rose 4.9% quarter-over-quarter to $7.3B.

Based on Bahl & Gaynor's 13F filing for Q4 2015, filed 12 Feb 2016.